123 related articles for article (PubMed ID: 37036274)
1. Revaccination of children with acute lymphoblastic leukemia following completion of chemotherapy.
Anafy A; Gilad G; Michaan N; Elhasid R; Rosenfeld-Kaidar H; Arad-Cohen N; Cohen MS; Shachor-Meyouhas Y; Grisaru-Soen G
Pediatr Blood Cancer; 2023 Jun; 70(6):e30321. PubMed ID: 37036274
[TBL] [Abstract][Full Text] [Related]
2. Protection against vaccine preventable diseases in children treated for acute lymphoblastic leukemia.
de de la Fuente Garcia I; Coïc L; Leclerc JM; Laverdière C; Rousseau C; Ovetchkine P; Tapiéro B
Pediatr Blood Cancer; 2017 Feb; 64(2):315-320. PubMed ID: 27718310
[TBL] [Abstract][Full Text] [Related]
3. Revaccination of children after completion of standard chemotherapy for acute leukemia.
Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT
Clin Infect Dis; 2007 Mar; 44(5):635-42. PubMed ID: 17278052
[TBL] [Abstract][Full Text] [Related]
4. Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens.
Nilsson A; De Milito A; Engström P; Nordin M; Narita M; Grillner L; Chiodi F; Björk O
Pediatrics; 2002 Jun; 109(6):e91. PubMed ID: 12042585
[TBL] [Abstract][Full Text] [Related]
5. Waning Vaccine Immunity and Vaccination Responses in Children Treated for Acute Lymphoblastic Leukemia: A Canadian Immunization Research Network Study.
Top KA; Vaudry W; Morris SK; Pham-Huy A; Pernica JM; Tapiéro B; Gantt S; Price VE; Rassekh SR; Sung L; McConnell A; Rubin E; Chawla R; Halperin SA
Clin Infect Dis; 2020 Dec; 71(9):e439-e448. PubMed ID: 32067048
[TBL] [Abstract][Full Text] [Related]
6. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S
Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078
[TBL] [Abstract][Full Text] [Related]
7. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.
Calaminus G; Hense B; Laws HJ; Groeger M; MacKenzie CR; Göbel U
Klin Padiatr; 2007; 219(6):355-60. PubMed ID: 18050047
[TBL] [Abstract][Full Text] [Related]
8. Immunization status and re-immunization of childhood acute lymphoblastic leukemia survivors.
Toret E; Yel SE; Suman M; Duzenli Kar Y; Ozdemir ZC; Dinleyici M; Bor O
Hum Vaccin Immunother; 2021 Apr; 17(4):1132-1135. PubMed ID: 32882157
[TBL] [Abstract][Full Text] [Related]
9. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
[TBL] [Abstract][Full Text] [Related]
10. Waning of Humoral Immunity to Vaccine-Preventable Diseases in Children Treated for Acute Lymphoblastic Leukemia: A Single-Center Retrospective Cross-Sectional Analysis.
İnce T; Tüfekçi Gürocak Ö; Totur G; Yılmaz Ş; Ören H; Aydın A
Turk J Haematol; 2024 May; ():. PubMed ID: 38801016
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of a liquid hexavalent DTaP-IPV-HB-PRP∼T vaccine after primary and booster vaccination of term and preterm infants born to women vaccinated with Tdap during pregnancy.
Maertens K; Orije MRP; Huoi C; Boisnard F; Lyabis O
Vaccine; 2023 Jan; 41(3):795-804. PubMed ID: 36528443
[TBL] [Abstract][Full Text] [Related]
12. Active immunization of children with leukemia and other malignancies.
Ridgway D; Wolff LJ
Leuk Lymphoma; 1993 Feb; 9(3):177-92. PubMed ID: 8471977
[TBL] [Abstract][Full Text] [Related]
13. Measles and rubella antibody status in children after treatment for acute lymphoblastic leukemia.
Volc SM; Almeida MT; Abadi MD; Cornacchioni AL; Odone Filho V; Cristofani LM
J Pediatr (Rio J); 2006; 82(6):481-4. PubMed ID: 17003944
[TBL] [Abstract][Full Text] [Related]
14. Assessment of immune response following immunization with DTP/Td and MMR vaccines in children treated for acute lymphoblastic leukemia.
Koochakzadeh L; Khosravi MH; Pourakbari B; Hosseinverdi S; Aghamohammadi A; Rezaei N
Pediatr Hematol Oncol; 2014 Oct; 31(7):656-63. PubMed ID: 25007393
[TBL] [Abstract][Full Text] [Related]
15. Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination.
Zengin E; Sarper N
Pediatr Blood Cancer; 2009 Dec; 53(6):967-72. PubMed ID: 19544393
[TBL] [Abstract][Full Text] [Related]
16. An observational, cohort, multi-centre, open label phase IV extension study comparing preschool DTAP-IPV booster vaccine responses in children whose mothers were randomised to one of two pertussis-containing vaccines or received no pertussis-containing vaccine in pregnancy in England.
Sapuan S; Andrews N; Hallis B; Hole L; Jones CE; Matheson M; Miller E; Snape MD; Heath PT
Vaccine; 2022 Nov; 40(49):7050-7056. PubMed ID: 36272877
[TBL] [Abstract][Full Text] [Related]
17. Revaccination of children after completion of standard chemotherapy for acute lymphoblastic leukaemia: a pilot study comparing different schedules.
Lehrnbecher T; Schubert R; Allwinn R; Dogan K; Koehl U; Grüttner HP
Br J Haematol; 2011 Mar; 152(6):754-7. PubMed ID: 21250973
[TBL] [Abstract][Full Text] [Related]
18. Differential loss of humoral immunity against measles, mumps, rubella and varicella-zoster virus in children treated for cancer.
Bochennek K; Allwinn R; Langer R; Becker M; Keppler OT; Klingebiel T; Lehrnbecher T
Vaccine; 2014 Jun; 32(27):3357-61. PubMed ID: 24793952
[TBL] [Abstract][Full Text] [Related]
19. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
[TBL] [Abstract][Full Text] [Related]
20. Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination.
Schure RM; Hendrikx LH; de Rond LG; Oztürk K; Sanders EA; Berbers GA; Buisman AM
Clin Vaccine Immunol; 2013 Sep; 20(9):1388-95. PubMed ID: 23825195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
